We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Aspen

3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Telephone: 003531 630 8400
Medical Information Direct Line: 0080000404142 - Freephone
Medical Information e-mail: aspenmedinfo@professionalinformation.co.uk
Patient Information Leaflet last updated on medicines.ie: 11/14/2017
PIL Septrin Paediatric 40mg/200mg per 5ml Oral Suspension.

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 11/14/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Updated on 11/17/2016 and displayed until 11/14/2017
Reasons for adding or updating:
  • Previous version of PIL reinstated
Updated on 11/15/2016 and displayed until 11/17/2016
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Improved presentation of PIL
Updated on 4/8/2014 and displayed until 11/15/2016
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 7/23/2013 and displayed until 4/8/2014
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 6/14/2013 and displayed until 7/23/2013
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 11/21/2012 and displayed until 6/14/2013
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 10/24/2012 and displayed until 11/21/2012
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 5/27/2011 and displayed until 10/24/2012
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 9/12/2008 and displayed until 5/27/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 5/23/2006 and displayed until 9/12/2008
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 10/12/2004 and displayed until 5/23/2006
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Trimethoprim
   Sulfamethoxazole